Similar articles

• [Modern principles of safety in erythrocytes-containing donor blood components transfusion].

  Bystrykh OA, Fedorova TA, Strel'nikova EV. Bystrykh OA, et al. Anesteziol Reanimatol. 2013 Nov-Dec;(6):57-9. Anesteziol Reanimatol. 2013. PMID: 24749268 Russian. No abstract available.
• [The erythrocyte phenotype in ABO and Rh blood groups in blood donors and blood recipients in a hospital setting of Cameroon: adapting supply to demand].

  Tagny CT, Fongué VF, Mbanya D. Tagny CT, et al. Rev Med Brux. 2009 May-Jun;30(3):159-62. Rev Med Brux. 2009. PMID: 19642486 French.
• Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings.

  Yazer MH, Spinella PC, Doyle L, Kaufman RM, Dunn R, Hess JR, Filho LA, Fontaine M, Gathof B, Jackson B, Murphy MF, Pasion J, Raval JS, Rosinski K, Seheult J, Shih AW, Sperry J, Staves J, Tuott EE, Ziman A, Triulzi DJ; Biomedical Excellence for Safer Transfusion Collaborative*. Yazer MH, et al. Anesthesiology. 2020 Mar;132(3):525-534. doi: 10.1097/ALN.0000000000003069. Anesthesiology. 2020. PMID: 31789634
• [Transfusion security "immunologic security"].

  Gargouri J, Brunot A, Souissi T. Gargouri J, et al. Tunis Med. 1995 Feb;73(2):109-17. Tunis Med. 1995. PMID: 9506152 Review. French. No abstract available.
• [Research advance on universal red blood cell engineering].

  Tan YX, Ji SP, Gong F. Tan YX, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):814-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21729578 Review. Chinese.